Dr. Lukas J. Farbiak is a biomedical engineering innovator and academic leader whose work in genetic medicine is transforming how diseases are treated at the molecular level. As an Assistant Professor at UT Southwestern and Co-Founder of Signify Bio, Inc., he merges deep scientific expertise with translational impact—developing advanced lipid nanoparticle platforms and signal peptide technologies that enable precise, tissue-specific delivery of therapeutic nucleic acids. With over 15 peer-reviewed publications and 20+ patent filings, Dr. Farbiak stands at the cutting edge of non-viral drug delivery and personalized therapeutics, bringing a rare blend of academic rigor, entrepreneurial vision, and collaborative leadership to every endeavor.